Blocked Pipeline Leads Teva’s US Generics To Fall Well Below $1bn Floor

As FX Headwinds Chip Hundreds Of Millions More From Top-Line Guidance

 
• By Dean Rudge
  
Filing_Cabinet
Several Teva filings are yet to receive final FDA approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business